Alx Oncology Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.00

+0.06 (+3.09%)

As of Aug 15, 2:16 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +1,186.5% upside

Low Target $15.89

Average Target $25.73

High Target $34.39

Current Price $2.00

Current
$2.00

Target
$25.73

$15.89 $25.73 avg $34.39

Scenario Analysis

Bear Case

$15.89

694.5%

Low target

Base Case

$25.73

+1,186.5%

Avg target

Bull Case

$34.39

+1,619.5%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.66

-24.8% from high

52-Week Low

$0.62

+224.1% from low

Target vs 52W High

$25.73

+867.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%